Manish S Bhandare (@manishbhandare4) 's Twitter Profile
Manish S Bhandare

@manishbhandare4

GI & HPB surgeon and Professor, TATA Memorial Hospital, Mumbai, India.

ID: 743858283929165826

calendar_today17-06-2016 17:30:09

1,1K Tweet

3,3K Followers

351 Following

JAMA Surgery (@jamasurgery) 's Twitter Profile Photo

A preoperative model and dichotomous criteria to determine the risk of futile pancreatectomy were developed. Results show the ability to predict futile pancreatectomy could help select patients for up-front resection or neoadjuvant therapy. ja.ma/3yaUnsW

A preoperative model and dichotomous criteria to determine the risk of futile pancreatectomy were developed. Results show the ability to predict futile pancreatectomy could help select patients for up-front resection or neoadjuvant therapy. ja.ma/3yaUnsW
anand mahindra (@anandmahindra) 's Twitter Profile Photo

If I was his opponent, I would cry foul & file a suit claiming that I was confronted by an unnatural opponent who possessed three arms… 😳 👍🏽💪🏽🇮🇳 x.com/thebetterindia…

Gurudutt P. Varty (@drguruduttvarty) 's Twitter Profile Photo

Manish S Bhandare Annals of Surgery Shailesh V. Shrikhande Tata Memorial Hospital Dr.Vikram Chaudhari Anant Ramaswamy Prabhat Bhargava, DM (Medical Oncology) Akshay Baheti Subhash Yadav Dr.RaviChandra Reddy Factors for poor OS T stage, Margin +, LN +, PNI, poor diff, PB subtype Factors for poor RFS T stage, LN +, poor diff, PNI, adj tissue invol Recurrences high [251/572 (61.7%), distant > local) Adjuvant therapy benefits 5-year OS (adj vs no adj) - 40.4%, vs. 32.3% (p – 0.012)

<a href="/Manishbhandare4/">Manish S Bhandare</a> <a href="/AnnalsofSurgery/">Annals of Surgery</a> <a href="/Shrikhande_SV/">Shailesh V. Shrikhande</a> <a href="/TataMemorial/">Tata Memorial Hospital</a> <a href="/DrVAChaudhari/">Dr.Vikram Chaudhari</a> <a href="/AnantRamaswamy/">Anant Ramaswamy</a> <a href="/bhargava611/">Prabhat Bhargava, DM (Medical Oncology)</a> <a href="/Dr_AkshayBaheti/">Akshay Baheti</a> <a href="/Subhash_YadavMD/">Subhash Yadav</a> <a href="/DrRaviChandra/">Dr.RaviChandra Reddy</a> Factors for poor OS
T stage, Margin +, LN +, PNI, poor diff, PB subtype

Factors for poor RFS
T stage, LN +, poor diff, PNI, adj tissue invol

Recurrences high [251/572 (61.7%), distant &gt; local)

Adjuvant therapy benefits
5-year OS (adj vs no adj) - 40.4%, vs. 32.3% (p – 0.012)
Gurudutt P. Varty (@drguruduttvarty) 's Twitter Profile Photo

Manish S Bhandare Annals of Surgery Shailesh V. Shrikhande Tata Memorial Hospital Dr.Vikram Chaudhari Anant Ramaswamy Prabhat Bhargava, DM (Medical Oncology) Akshay Baheti Subhash Yadav Dr.RaviChandra Reddy How well did CA 19-9 perform in predicting recurrence? Static as well as dynamic CA 19-9 parameters used ‘Serial rise’ or ‘first raised value > 200’ are almost always associated with recurrence Relative rise of CA 19-9 is an important dynamic parameter.

<a href="/Manishbhandare4/">Manish S Bhandare</a> <a href="/AnnalsofSurgery/">Annals of Surgery</a> <a href="/Shrikhande_SV/">Shailesh V. Shrikhande</a> <a href="/TataMemorial/">Tata Memorial Hospital</a> <a href="/DrVAChaudhari/">Dr.Vikram Chaudhari</a> <a href="/AnantRamaswamy/">Anant Ramaswamy</a> <a href="/bhargava611/">Prabhat Bhargava, DM (Medical Oncology)</a> <a href="/Dr_AkshayBaheti/">Akshay Baheti</a> <a href="/Subhash_YadavMD/">Subhash Yadav</a> <a href="/DrRaviChandra/">Dr.RaviChandra Reddy</a> How well did CA 19-9 perform in predicting recurrence?

Static as well as dynamic CA 19-9 parameters used

‘Serial rise’ or ‘first raised value &gt; 200’ are almost always associated with recurrence

Relative rise of CA 19-9 is an important dynamic parameter.
Gurudutt P. Varty (@drguruduttvarty) 's Twitter Profile Photo

Manish S Bhandare Annals of Surgery Shailesh V. Shrikhande Tata Memorial Hospital Dr.Vikram Chaudhari Anant Ramaswamy Prabhat Bhargava, DM (Medical Oncology) Akshay Baheti Subhash Yadav Dr.RaviChandra Reddy Rise in CA 19-9 precedes radiological recurrence by 4.04 months Recurrence detected by CA 19-9 rise -->Early therapy -->survival benefit Recurrence detection after CA 19-9 elevation has better survival than recurrence detection without elevation (12.8 vs 7.6 months, p – 0.005)

<a href="/Manishbhandare4/">Manish S Bhandare</a> <a href="/AnnalsofSurgery/">Annals of Surgery</a> <a href="/Shrikhande_SV/">Shailesh V. Shrikhande</a> <a href="/TataMemorial/">Tata Memorial Hospital</a> <a href="/DrVAChaudhari/">Dr.Vikram Chaudhari</a> <a href="/AnantRamaswamy/">Anant Ramaswamy</a> <a href="/bhargava611/">Prabhat Bhargava, DM (Medical Oncology)</a> <a href="/Dr_AkshayBaheti/">Akshay Baheti</a> <a href="/Subhash_YadavMD/">Subhash Yadav</a> <a href="/DrRaviChandra/">Dr.RaviChandra Reddy</a> Rise in CA 19-9 precedes radiological recurrence by 4.04 months

Recurrence detected by CA 19-9 rise --&gt;Early therapy --&gt;survival benefit

Recurrence detection after CA 19-9 elevation has better survival than recurrence detection without elevation (12.8 vs 7.6 months, p – 0.005)
Shravan Nadkarni (@oncoshravan) 's Twitter Profile Photo

BALCO Medical Centre, New Raipur is hosting d annual Cancer Conclave (September 20-22) Join us for Live surgery - Whipple Procedure & Radical Gastrectomy + D2 Lymphadenectomy by Prof Shailesh V. Shrikhande & Prof Manish S Bhandare from Tata Memorial Hospital, Mumbai. Reg link - t.ly/2mR0a

<a href="/BalcoMedical/">BALCO Medical Centre</a>, New Raipur is hosting d annual Cancer Conclave (September 20-22)

Join us for Live surgery - Whipple Procedure &amp; Radical Gastrectomy + D2 Lymphadenectomy by Prof <a href="/Shrikhande_SV/">Shailesh V. Shrikhande</a> &amp; Prof <a href="/Manishbhandare4/">Manish S Bhandare</a> from <a href="/TataMemorial/">Tata Memorial Hospital</a>, Mumbai. 

Reg link - t.ly/2mR0a
sanket sharad mehta (@sanket86024322) 's Twitter Profile Photo

LAPC cases post-chemotherapy can pose significant challenges. In such situations, total pancreatectomy with vessel divestment may be the necessary option for salvage. Grateful to Shailesh V. Shrikhande Manish S Bhandare and their team for inspiring us to take on such complex cases.

Deeksha Kapoor (@deekshakapoor1) 's Twitter Profile Photo

It’s time for “site-specific” prediction of CR-POPF after PD! Our latest publication in the Annals of Surgery demonstrates that the 2-factor ISGPS Classification of High-Risk Pancreas underperforms in predicting the risk of CRPF in periampullary tumours. Shailesh V. Shrikhande

It’s time for “site-specific” prediction of CR-POPF after PD!

Our latest publication in the Annals of Surgery demonstrates that the 2-factor ISGPS Classification of High-Risk Pancreas underperforms in predicting the risk of CRPF in periampullary tumours.
<a href="/Shrikhande_SV/">Shailesh V. Shrikhande</a>
Shravan Nadkarni (@oncoshravan) 's Twitter Profile Photo

BALCO Medical Centre, New Raipur is hosting the Annual Cancer Conclave on Sep 20-22 2024. Live surgery by Shailesh V. Shrikhande & Manish S Bhandare Hands-on Workshops on Lap Bowel Suturing & HJ-PJ Anastomosis on porcine pancreas supported by Ethicon and conducted by Dr. Saneya

<a href="/BalcoMedical/">BALCO Medical Centre</a>, New Raipur is hosting the Annual Cancer Conclave on Sep 20-22 2024. 

Live surgery by <a href="/Shrikhande_SV/">Shailesh V. Shrikhande</a> &amp; <a href="/Manishbhandare4/">Manish S Bhandare</a> 

Hands-on Workshops on Lap Bowel Suturing &amp; HJ-PJ Anastomosis on porcine pancreas supported by <a href="/Ethicon/">Ethicon</a> and conducted by <a href="/Saneya_2810/">Dr. Saneya</a>